Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FHCY4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,203
Award facts
- Contract value 100% obligated
- $13,203.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,203.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The award, issued on December 8, 2025, is a non-set-aside delivery order with an ultimate completion date of December 30, 2025. This award falls under DMS Pharmaceutical Group's recently established Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was awarded on November 13, 2025, with a $499.9 billion ceiling value and completion date of December 31, 2036.
The PPV-G GEN V represents a $30.3 billion Defense Logistics Agency acquisition strategy designed to supply pharmaceutical products and medical consumables to military healthcare facilities worldwide. As a prime vendor contractor under this program, DMS Pharmaceutical Group is authorized to receive firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical supplies supporting Department of Defense healthcare operations. The company's established performance across a comprehensive portfolio of therapeutic categories, including specialty pharmaceuticals and injectable biologics, demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FHCY4?
SPE2DR26FHCY4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FHCY4 worth?
The government has obligated $13,203 on SPE2DR26FHCY4.
Is contract SPE2DR26FHCY4 an order under another contract?
Yes. SPE2DR26FHCY4 is a delivery order under SPE2DR25D9207, an indefinite delivery contract.
Was contract SPE2DR26FHCY4 competed?
The extent of competition for SPE2DR26FHCY4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award